Retrospective studies in patients with HNSCC showed that high levels of IDO expression are correlated with worse outcomes and a poorer prognosis, probably owing to the direct association of IDO with regulatory T cells (T-Reg). This evidence concerns the gene IDO1 and head and neck squamous cell carcinoma.